AlphaGrep UK’s Doximity DOCS Stock Holding History

AlphaGrep UK’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$763K	Sell	26,925 -5,688	-17%	-$137K	0.23%	84
2026 Q2	$676K	Buy	32,613 +9,976	+44%	+$221K	0.2%	129
2026 Q1	$527K	Buy	22,637 +6,991	+45%	+$218K	0.15%	224
2025 Q4	$693K	Buy	+15,646	New	+$878K	0.23%	105

Other funds holding DOCS

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

AlphaGrep UK's DOCS Position: Q3 2026 in Review

AlphaGrep UK reduced its Doximity (DOCS) stake by 17% in Q3 2026, selling an estimated $137K and leaving 26,925 shares worth $763K. The position accounts for 0.23% of the portfolio, ranked #84.

AlphaGrep UK first reported a position in DOCS in Q4 2025 and has held it in 4 quarters since. 320 funds tracked by Wall St. Rank hold DOCS as of Q3 2026.

AlphaGrep UK held 26,925 shares of Doximity worth $763K as of Q3 2026.
AlphaGrep UK sold 5,688 Doximity shares in Q3 2026, an estimated $137K.
Doximity made up 0.23% of AlphaGrep UK's portfolio in Q3 2026, its #84 holding.
AlphaGrep UK first reported a position in Doximity in Q4 2025 and has held it in 4 quarters since.
320 funds tracked by Wall St. Rank held Doximity as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.